Ligand · L09

L09 · N-(3-tert-butyl-1H-pyrazol-5-yl)-N'-{4-chloro-3-[(pyridin-3-yloxy)methyl]phenyl}urea

L09, N-(3-tert-butyl-1H-pyrazol-5-yl)-N'-{4-chloro-3-[(pyridin-3-yloxy)methyl]phenyl}urea (C20 H22 Cl N5 O2, 399.9 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within…

Component: L09
Formula: C20 H22 Cl N5 O2
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

L09 in 2 structures; the first of them:

1WBN · fragment based p38 inhibitors · L09 A1355 · binds VAL30, VAL38, ALA51, VAL52, LYS53, GLU71, LEU74, LEU75 and 15 more
1WBN · Fragment based P38 inhibitors · L09 A1355 · binds VAL30, VAL38, ALA51, VAL52, LYS53, GLU71, LEU74, LEU75 and 15 more

Residues it binds most

LEU 2, ILE 2, VAL 2, HIS 2, MET 2, ALA 2, ASP 2, GLU 2, LYS 2, PHE 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.